Ceftibuten

Thông số

97519-39-6Số CAS

810-182-0Số EC

(6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidTên IUPAC

C15H14N4O6S2Công thức hóa học

410.4 g/molKhối lượng phân tử

ceftibuten; 97519-39-6; Ceftibuteno; Ceftibutene; Ceftibutenum; Sch 39720; cis-ceftibuten; Sch-39720; 7432-S; DTXSID4045925; Ceftibutin; ACHN383; NSC-758925; ACHN-383; CHEBI:3510; IW71N46B4Y; (+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; DTXCID2025925; PF-06264006; (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-; PF-07612577 component PF-06264006; (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-(((Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-((2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; SCH39720; RefChem:56370; J01DA39; 7-(2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino)-3-cephem-4-carboxylic acid; Cedax; Ceftibuten-13C3; C15H14N4O6S2; Antibiotic 7432S; cis-Ceftibutin; Cephalosporin 7432-S; 118081-37-1; (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Ceftibutene [INN-French]; Ceftibutenum [INN-Latin]; Ceftibuteno [INN-Spanish]; UNII-IW71N46B4Y; Ceprifran; Ceftem; Keimax; Ceftibuten [USAN:INN:BAN]; MFCD00864918; S 7432; NCGC00095137-01; 97519-39-6 (free); CEFTIBUTEN [MI]; CEFTIBUTEN [INN]; Ceftibuten (USAN/INN); Spectrum5_001558; CEFTIBUTEN [USAN]; CEFTIBUTEN [VANDF]; CEFTIBUTIN [VANDF]; CEFTIBUTEN [WHO-DD]; CHEMBL1605; Epitope ID:1083492; SCHEMBL37054; BSPBio_002733; SPECTRUM1505207; orb1710096; GTPL12029; HMS1922L17; HMS2093K18; HMS3715P10; Pharmakon1600-01505207; HY-B0698; Tox21_111446; BDBM50370586; CCG-39440; EBC-26987; NSC758925; AKOS005146205; AKOS015854930; DB01415; NSC 758925; NCGC00178501-01; NCGC00178501-04; FC176429; SBI-0206740.P001; CAS-97519-39-6; C3391; NS00001036; C08117; D00922; T10753; AB01563048_01; EN300-21702502; Q419521; SR-05000001989; SR-05000001989-1; BRD-K11124378-001-04-6; BRD-K11124378-002-01-0; BRD-K11124378-335-01-4; BRD-K11124378-335-02-2; (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; (6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-4-carboxy-but-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((2-(2-AMINO-4-THIAZOLYL)-4-CARBOXY-1-OXO-2-BUTENYL)AMINO)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(Z)))-; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acidTên gọi khác